| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Sola-Campoy, Pedro Juan |
| dc.contributor.author | Delgado-Valverde, Mercedes |
| dc.contributor.author | Cano, María E. |
| dc.contributor.author | Gijón, Desirèe |
| dc.contributor.author | Larrosa Escartin, María Nieves |
| dc.contributor.author | Gonzalez Lopez, Juan Jose |
| dc.contributor.author | Cañada-Garcia, Javier E. |
| dc.contributor.author | Moure Garcia, Zaira |
| dc.date.accessioned | 2022-10-04T12:27:37Z |
| dc.date.available | 2022-10-04T12:27:37Z |
| dc.date.issued | 2022-06-30 |
| dc.identifier.citation | Cañada-García JE, Moure Z, Sola-Campoy PJ, Delgado-Valverde M, Cano ME, Gijón D, et al. CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumonia e and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3. Front Microbiol. 2022 Jun 30;13:918362. |
| dc.identifier.issn | 1664-302X |
| dc.identifier.uri | https://hdl.handle.net/11351/8253 |
| dc.description | Carbapenemases; High-risk clones; Whole genome sequencing |
| dc.description.abstract | Objectives: CARB-ES-19 is a comprehensive, multicenter, nationwide study integrating whole-genome sequencing (WGS) in the surveillance of carbapenemase-producing K. pneumoniae (CP-Kpn) and E. coli (CP-Eco) to determine their incidence, geographical distribution, phylogeny, and resistance mechanisms in Spain.
Methods: In total, 71 hospitals, representing all 50 Spanish provinces, collected the first 10 isolates per hospital (February to May 2019); CPE isolates were first identified according to EUCAST (meropenem MIC > 0.12 mg/L with immunochromatography, colorimetric tests, carbapenem inactivation, or carbapenem hydrolysis with MALDI-TOF). Prevalence and incidence were calculated according to population denominators. Antibiotic susceptibility testing was performed using the microdilution method (EUCAST). All 403 isolates collected were sequenced for high-resolution single-nucleotide polymorphism (SNP) typing, core genome multilocus sequence typing (cgMLST), and resistome analysis.
Results: In total, 377 (93.5%) CP-Kpn and 26 (6.5%) CP-Eco isolates were collected from 62 (87.3%) hospitals in 46 (92%) provinces. CP-Kpn was more prevalent in the blood (5.8%, 50/853) than in the urine (1.4%, 201/14,464). The cumulative incidence for both CP-Kpn and CP-Eco was 0.05 per 100 admitted patients. The main carbapenemase genes identified in CP-Kpn were blaOXA–48 (263/377), blaKPC–3 (62/377), blaVIM–1 (28/377), and blaNDM–1 (12/377). All isolates were susceptible to at least two antibiotics. Interregional dissemination of eight high-risk CP-Kpn clones was detected, mainly ST307/OXA-48 (16.4%), ST11/OXA-48 (16.4%), and ST512-ST258/KPC (13.8%). ST512/KPC and ST15/OXA-48 were the most frequent bacteremia-causative clones. The average number of acquired resistance genes was higher in CP-Kpn (7.9) than in CP-Eco (5.5).
Conclusion: This study serves as a first step toward WGS integration in the surveillance of carbapenemase-producing Enterobacterales in Spain. We detected important epidemiological changes, including increased CP-Kpn and CP-Eco prevalence and incidence compared to previous studies, wide interregional dissemination, and increased dissemination of high-risk clones, such as ST307/OXA-48 and ST512/KPC-3. |
| dc.language.iso | eng |
| dc.publisher | Frontiers Media |
| dc.relation.ispartofseries | Frontiers in Microbiology;13 |
| dc.rights | Attribution 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
| dc.source | Scientia |
| dc.subject | Medicaments antibacterians |
| dc.subject | Escheríchia coli |
| dc.subject | Enzimologia |
| dc.subject.mesh | Klebsiella pneumoniae |
| dc.subject.mesh | Escherichia coli |
| dc.subject.mesh | /enzymology |
| dc.subject.mesh | Anti-Bacterial Agents |
| dc.title | CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3 |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.3389/fmicb.2022.918362 |
| dc.subject.decs | Klebsiella pneumoniae |
| dc.subject.decs | Escherichia coli |
| dc.subject.decs | /enzimología |
| dc.subject.decs | antibacterianos |
| dc.relation.publishversion | https://doi.org/10.3389/fmicb.2022.918362 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [Cañada-García JE, Moure Z, Sola-Campoy PJ] Laboratorio de Referencia e Investigación en Resistencia a Antibióticos e Infecciones Relacionadas con la Asistencia Sanitaria, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain. [Delgado-Valverde M] Unidad de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Instituto de Biomedicina de Sevilla (Hospital Universitario Virgen Macarena/CSIC/Universidad de Sevilla), Seville, Spain. CIBER de Enfermedades Infecciosas (CIBERINFEC), REIPI, Instituto de Salud Carlos III, Madrid, Spain. [Cano ME] Servicio de Microbiología, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. [Gijón D] CIBER de Enfermedades Infecciosas (CIBERINFEC), REIPI, Instituto de Salud Carlos III, Madrid, Spain. Servicio de Microbiología, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain. [Larrosa N, González-López JJ] CIBER de Enfermedades Infecciosas (CIBERINFEC), REIPI, Instituto de Salud Carlos III, Madrid, Spain. Servei de Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Genètica i Microbiologia, Universitat Autònoma de Barcelona, Bellaterra, Spain |
| dc.identifier.pmid | 35847090 |
| dc.identifier.wos | 000826714200001 |
| dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/PI18CIII%2F00030 |
| dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/PI21CIII%2F00039 |
| dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/RD16%2F0016%2F0003 |
| dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/CB21%2F13%2F00054 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |